Laurie H. GlimcherBenjamin Levine EbertLaurie H. Glimcher will step down as Dana-Farber Cancer Institute president and CEO on Oct. 1.
The Advanced Research Projects Agency for Health announced the first eight teams selected by its Precision Surgical Interventions, or PSI, program to receive awards.
Bill King, a researcher with the University of Illinois Urbana-Champaign, received a $18.7 million award from the Advanced Research Projects Agency for Health to develop a novel platform to manufacture tumor models and dramatically expand their availability for both medical research and personalized medicine.
McKesson Corp. has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures LLC (Core Ventures).
A partnership between Florida Cancer Specialists & Research Institute and Paradigm Health Inc. will provide patients in Florida with more access to new treatment options through participation in clinical trials.
Simon Nazarian was named executive vice president and chief digital and technology officer at City of Hope. He will join the institution on Sept. 9.
Omer F. Awan was named vice president and chief information officer at Fred Hutchinson Cancer Center, effective Sept. 25.
Jonathan H. Sherman has been appointed chief of neurosurgical oncology at Rutgers Cancer Institute.
Abhisek Swaika was named medical director of the Northwell Health Cancer Institute at Rego Park and chief of hematology/oncology at Long Island Jewish Forest Hills Hospital.
The UCSF Prostate Cancer Program received the NCI’s Specialized Programs of Research Excellence, or SPORE, grant for prostate cancer.
